Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?
- PMID: 20833283
- DOI: 10.1016/j.ygyno.2010.08.011
Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?
Comment on
-
The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: survey results from members of the Society of Gynecologic Oncologists.Gynecol Oncol. 2010 Oct;119(1):18-21. doi: 10.1016/j.ygyno.2010.06.021. Epub 2010 Jul 31. Gynecol Oncol. 2010. PMID: 20673970
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
